Refractory angina

Mohammad Sarraf; Daniel J. Hellrung; Timothy D. Henry

doi:10.1007/978-1-4614-1475-9_24

Refractory angina

Mohammad Sarraf, Daniel J. Hellrung, Timothy D. Henry

Medicine - Cardiology Division

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

A growing number of patients have refractory angina - but limited therapeutic options. Revascularization, medical therapy, and risk factor modification have improved notably, but these patients are left with severe limitations in their quality of life. As described in this chapter, an increasing number of pharmacologic and nonpharmacologic approaches for no-option patients are making quality-of-life inroads for this challenging patient population.

Original language	English (US)
Title of host publication	Coronary Heart Disease
Subtitle of host publication	Clinical, Pathological, Imaging, and Molecular Profiles
Publisher	Springer US
Pages	431-443
Number of pages	13
Volume	9781461414759
ISBN (Electronic)	9781461414759
ISBN (Print)	1461414741, 9781461414742
DOIs	https://doi.org/10.1007/978-1-4614-1475-9_24
State	Published - Jun 1 2012

Bibliographical note

Publisher Copyright:
© 2012 Springer Science+Business Media, LLC. All rights reserved.

Access

10.1007/978-1-4614-1475-9_24

OpenUrl availability

Full text

Cite this

@inbook{944b607c7c0a421c8b6d695a2f8c4f7f,

title = "Refractory angina",

abstract = "A growing number of patients have refractory angina - but limited therapeutic options. Revascularization, medical therapy, and risk factor modification have improved notably, but these patients are left with severe limitations in their quality of life. As described in this chapter, an increasing number of pharmacologic and nonpharmacologic approaches for no-option patients are making quality-of-life inroads for this challenging patient population.",

author = "Mohammad Sarraf and Hellrung, {Daniel J.} and Henry, {Timothy D.}",

year = "2012",

month = jun,

day = "1",

doi = "10.1007/978-1-4614-1475-9_24",

language = "English (US)",

isbn = "1461414741",

volume = "9781461414759",

pages = "431--443",

booktitle = "Coronary Heart Disease",

publisher = "Springer US",

}

TY - CHAP

T1 - Refractory angina

AU - Sarraf, Mohammad

AU - Hellrung, Daniel J.

AU - Henry, Timothy D.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - A growing number of patients have refractory angina - but limited therapeutic options. Revascularization, medical therapy, and risk factor modification have improved notably, but these patients are left with severe limitations in their quality of life. As described in this chapter, an increasing number of pharmacologic and nonpharmacologic approaches for no-option patients are making quality-of-life inroads for this challenging patient population.

AB - A growing number of patients have refractory angina - but limited therapeutic options. Revascularization, medical therapy, and risk factor modification have improved notably, but these patients are left with severe limitations in their quality of life. As described in this chapter, an increasing number of pharmacologic and nonpharmacologic approaches for no-option patients are making quality-of-life inroads for this challenging patient population.

UR - http://www.scopus.com/inward/record.url?scp=84949180402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949180402&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-1475-9_24

DO - 10.1007/978-1-4614-1475-9_24

M3 - Chapter

AN - SCOPUS:84949180402

SN - 1461414741

SN - 9781461414742

VL - 9781461414759

SP - 431

EP - 443

BT - Coronary Heart Disease

PB - Springer US

ER -

Refractory angina

Abstract

Bibliographical note

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this